Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study-Reference-Cited by-同舟云学术

Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study

Published:2021-06-21 Issue:3 Volume:39 Page:115-119
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Fitzcharles Mary-Ann¹,Rampakakis Emmanouil²,Sampalis John S.³,Shir Yoram⁴,Cohen Martin⁵,Starr Michael⁵,Häuser Winfried⁶

Affiliation:

1. Division of Rheumatology, McGill University Health Centre, Montreal, and Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada. mary-ann.fitzcharles@muhc.mcgill.ca

2. JSS Medical Research, St-Laurent, Canada.

3. JSS Medical Research, St-Laurent, and Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

4. Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Canada.

5. Division of Rheumatology, McGill University Health Centre, Montreal, Canada.

6. Department Internal Medicine I, Klinikum Saarbrücken, and Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Germany.

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Elusive Truth of Cannabinoids for Rheumatic Pain;Current Rheumatology Reports;2024-08-09

2. Is a Low Dosage of Medical Cannabis Effective for Treating Pain Related to Fibromyalgia? A Pilot Study and Systematic Review;Journal of Clinical Medicine;2024-07-12

3. Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology;Brazilian Journal of Anesthesiology (English Edition);2024-07

4. Cannabis therapy in rheumatological diseases: A systematic review;Northern Clinics of Istanbul;2024

5. Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs;Deutsches Ärzteblatt international;2023-12-08